MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype. [electronic resource]
Producer: 20160229Description: 11676-82 p. digitalISSN:- 1949-2553
- Adult
- Antineoplastic Agents, Alkylating -- therapeutic use
- Asian People
- Biomarkers, Tumor -- genetics
- Brain Neoplasms -- drug therapy
- China -- epidemiology
- Cluster Analysis
- Dacarbazine -- analogs & derivatives
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- metabolism
- Female
- Gene Expression Profiling -- methods
- Gene Expression Regulation, Neoplastic
- Glioblastoma -- drug therapy
- Humans
- Isocitrate Dehydrogenase -- genetics
- Kaplan-Meier Estimate
- Ki-67 Antigen -- metabolism
- Male
- MicroRNAs -- genetics
- Middle Aged
- Mutation
- Oligonucleotide Array Sequence Analysis
- Predictive Value of Tests
- Real-Time Polymerase Chain Reaction
- Reproducibility of Results
- Temozolomide
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.